跳至主要内容
临床试验/NCT06382857
NCT06382857招募中不适用

Effectiveness of a Microbiome-directed Food to Promote Programmatic and Sustained Nutritional Recovery Among Children With Uncomplicated Acute Malnutrition

Epicentre1 个研究点 分布在 1 个国家目标入组 7,356 人开始时间: 2024年5月2日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Epicentre
入组人数
7,356
试验地点
1
主要终点
Sustained recovery at 24 weeks from admission

研究概览

简要总结

This study is an individually randomized controlled trial comparing microbiome-directed foods to standard nutritional therapy among children aged 6 to < 24 months with uncomplicated acute malnutrition in terms of programmatic recovery by 12 weeks from admission and sustained recovery at 24 weeks from admission.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
6 Months 至 23 Months(Child)
性别
All
接受健康志愿者

入选标准

  • for children with Severe Acute Malnutrition (SAM): MUAC < 115 mm and/or WLZ < -3 and/or mild (+) or moderate (++) edema
  • for children with Moderate Acute Malnutrition (MAM): 115 mm ≤ MUAC < 125 mm and/or -3 ≤ WHZ < -2
  • Caregiver providing informed consent

排除标准

  • Medical complications requiring inpatient treatment, as identified by the national protocol
  • Not eating/lack of appetite (as informed by appetite test and investigator judgement)
  • Re-admission into the program within 2 months of previous default
  • for children with Severe Acute Malnutrition (SAM): Referral from inpatient care (therapeutic feeding center, TFC) or supplementary feeding program (SFP)
  • for children with Moderate Acute Malnutrition (MAM): Referral from SAM treatment (TFC or OTP)
  • Presence of congenital abnormality or underlying chronic disease that may affect growth or risk of infection
  • Known contraindication/ hypersensitivity/allergy to study interventions (chickpea/soy flour, banana, peanut)
  • Residence outside the study catchment area or in a non-fixed (e.g. nomadic) community

结局指标

主要结局

Sustained recovery at 24 weeks from admission

时间窗: 24 weeks

Proportion of recovered SAM and MAM children with WLZ ≥ -2 AND MUAC ≥ 125mm AND no edema

Programmatic recovery by 12 weeks from admission

时间窗: 12 weeks

Defined as the proportion of SAM and MAM children achieving a WLZ ≥ -2 AND MUAC ≥ 125mm AND no edema during 2 consecutive visits

次要结局

  • Change in MUAC(From enrollment to 4, 8 and 12 weeks)
  • Hospitalization(24 weeks)
  • Non-response(12 weeks)
  • Time to recovery(12 weeks)
  • For MAM children: Deterioration to SAM(24 weeks)
  • Change in weight gain(From enrollment to 4, 8 and 12 weeks)
  • Change in weight-for-length Z (WLZ)(From enrollment to 4, 8 and 12 weeks)
  • Change in weight-for-age Z (WAZ)(From enrollment to 4, 8 and 12 weeks)
  • Default(12 weeks)
  • Change in length-for-age Z (LAZ)(From enrollment to 4, 8 and 12 weeks)
  • Serious adverse events(24 weeks)
  • Death(24 weeks)
  • Dietary intake(24 weeks)
  • Adherence(12 weeks)
  • Immuno-sufficiency at week 2, week 4, program discharge, week 12 and study discharge (SAM only)(24 weeks)
  • Motor, cognitive, language, social-emotional, and mental health skills(24 weeks)
  • Cost effectiveness(24 weeks)
  • Microbiome profile at enrollment, week 4, program discharge, and study discharge(24 weeks)
  • Plasma proteome profile at enrollment, week 4, program discharge, and study discharge(24 weeks)
  • Micronutrient status at enrollment, program discharge and study discharge(24 weeks)
  • Environmental enteric dysfunction at enrollment, program discharge, and study discharge(24 weeks)
  • Change of fat mass and fat-free mass at program discharge and study discharge(24 weeks)

研究者

发起方
Epicentre
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sheila Isanaka

Associate Professor

Harvard School of Public Health (HSPH)

研究点 (1)

Loading locations...

相似试验